Literature DB >> 29483265

Expanded cellular clones carrying replication-competent HIV-1 persist, wax, and wane.

Zheng Wang1, Evelyn E Gurule1, Timothy P Brennan1, Jeffrey M Gerold2, Kyungyoon J Kwon1, Nina N Hosmane1, Mithra R Kumar1, Subul A Beg1, Adam A Capoferri1, Stuart C Ray1, Ya-Chi Ho3, Alison L Hill2, Janet D Siliciano1, Robert F Siliciano4,5.   

Abstract

The latent reservoir for HIV-1 in resting CD4+ T cells is a major barrier to cure. Several lines of evidence suggest that the latent reservoir is maintained through cellular proliferation. Analysis of this proliferative process is complicated by the fact that most infected cells carry defective proviruses. Additional complications are that stimuli that drive T cell proliferation can also induce virus production from latently infected cells and productively infected cells have a short in vivo half-life. In this ex vivo study, we show that latently infected cells containing replication-competent HIV-1 can proliferate in response to T cell receptor agonists or cytokines that are known to induce homeostatic proliferation and that this can occur without virus production. Some cells that have proliferated in response to these stimuli can survive for 7 d while retaining the ability to produce virus. This finding supports the hypothesis that both antigen-driven and cytokine-induced proliferation may contribute to the stability of the latent reservoir. Sequencing of replication-competent proviruses isolated from patients at different time points confirmed the presence of expanded clones and demonstrated that while some clones harboring replication-competent virus persist longitudinally on a scale of years, others wax and wane. A similar pattern is observed in longitudinal sampling of residual viremia in patients. The observed patterns are not consistent with a continuous, cell-autonomous, proliferative process related to the HIV-1 integration site. The fact that the latent reservoir can be maintained, in part, by cellular proliferation without viral reactivation poses challenges to cure.

Entities:  

Keywords:  HIV persistence; clonal expansion; latent reservoir

Mesh:

Year:  2018        PMID: 29483265      PMCID: PMC5856552          DOI: 10.1073/pnas.1720665115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  52 in total

1.  Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.

Authors:  Janet D Siliciano; Joleen Kajdas; Diana Finzi; Thomas C Quinn; Karen Chadwick; Joseph B Margolick; Colin Kovacs; Stephen J Gange; Robert F Siliciano
Journal:  Nat Med       Date:  2003-05-18       Impact factor: 53.440

2.  Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.

Authors:  T W Chun; L Stuyver; S B Mizell; L A Ehler; J A Mican; M Baseler; A L Lloyd; M A Nowak; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

3.  Loss of IL-7Ralpha is associated with CD4 T-cell depletion, high interleukin-7 levels and CD28 down-regulation in HIV infected patients.

Authors:  Bence Rethi; Caroline Fluur; Ann Atlas; Malgorzata Krzyzowska; Frida Mowafi; Sven Grützmeier; Angelo De Milito; Rino Bellocco; Kerstin I Falk; Eva Rajnavölgyi; Francesca Chiodi
Journal:  AIDS       Date:  2005-12-02       Impact factor: 4.177

4.  Interleukin-7 induces expression of latent human immunodeficiency virus type 1 with minimal effects on T-cell phenotype.

Authors:  Deirdre D Scripture-Adams; David G Brooks; Yael D Korin; Jerome A Zack
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

5.  Productive infection maintains a dynamic steady state of residual viremia in human immunodeficiency virus type 1-infected persons treated with suppressive antiretroviral therapy for five years.

Authors:  Diane V Havlir; Matthew C Strain; Mario Clerici; Caroline Ignacio; Daria Trabattoni; Pasquale Ferrante; Joseph K Wong
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

6.  HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation.

Authors:  Nicolas Chomont; Mohamed El-Far; Petronela Ancuta; Lydie Trautmann; Francesco A Procopio; Bader Yassine-Diab; Geneviève Boucher; Mohamed-Rachid Boulassel; Georges Ghattas; Jason M Brenchley; Timothy W Schacker; Brenna J Hill; Daniel C Douek; Jean-Pierre Routy; Elias K Haddad; Rafick-Pierre Sékaly
Journal:  Nat Med       Date:  2009-06-21       Impact factor: 53.440

7.  Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection.

Authors:  T W Chun; D Engel; M M Berrey; T Shea; L Corey; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

8.  Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells.

Authors:  Benedict Seddon; Peter Tomlinson; Rose Zamoyska
Journal:  Nat Immunol       Date:  2003-06-15       Impact factor: 25.606

9.  HIV persistence in tissue macrophages of humanized myeloid-only mice during antiretroviral therapy.

Authors:  Jenna B Honeycutt; William O Thayer; Caroline E Baker; Ruy M Ribeiro; Steven M Lada; Youfang Cao; Rachel A Cleary; Michael G Hudgens; Douglas D Richman; J Victor Garcia
Journal:  Nat Med       Date:  2017-04-17       Impact factor: 53.440

10.  Rapid quantification of the latent reservoir for HIV-1 using a viral outgrowth assay.

Authors:  Gregory M Laird; Evelyn E Eisele; S Alireza Rabi; Jun Lai; Stanley Chioma; Joel N Blankson; Janet D Siliciano; Robert F Siliciano
Journal:  PLoS Pathog       Date:  2013-05-30       Impact factor: 6.823

View more
  110 in total

Review 1.  The multifaceted nature of HIV latency.

Authors:  Caroline Dufour; Pierre Gantner; Rémi Fromentin; Nicolas Chomont
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

2.  Genetic complexity in the replication-competent latent HIV reservoir increases with untreated infection duration in infected youth.

Authors:  Zabrina L Brumme; Hanwei Sudderuddin; Carrie Ziemniak; Katherine Luzuriaga; Bradley R Jones; Jeffrey B Joy; Coleen K Cunningham; Thomas Greenough; Deborah Persaud
Journal:  AIDS       Date:  2019-02-01       Impact factor: 4.177

3.  HIV-1 latent reservoir size and diversity are stable following brief treatment interruption.

Authors:  D Brenda Salantes; Yu Zheng; Felicity Mampe; Tuhina Srivastava; Subul Beg; Jun Lai; Jonathan Z Li; Randall L Tressler; Richard A Koup; James Hoxie; Mohamed Abdel-Mohsen; Scott Sherrill-Mix; Kevin McCormick; E Turner Overton; Frederic D Bushman; Gerald H Learn; Robert F Siliciano; Janet M Siliciano; Pablo Tebas; Katharine J Bar
Journal:  J Clin Invest       Date:  2018-06-18       Impact factor: 14.808

Review 4.  Review: HIV-1 phylogeny during suppressive antiretroviral therapy.

Authors:  Michael J Bale; Mary F Kearney
Journal:  Curr Opin HIV AIDS       Date:  2019-05       Impact factor: 4.283

5.  Immune Control of HIV.

Authors:  Muthukumar Balasubramaniam; Jui Pandhare; Chandravanu Dash
Journal:  J Life Sci (Westlake Village)       Date:  2019-06

Review 6.  Multifaceted HIV integrase functionalities and therapeutic strategies for their inhibition.

Authors:  Alan N Engelman
Journal:  J Biol Chem       Date:  2019-08-29       Impact factor: 5.157

7.  Abundant HIV-infected cells in blood and tissues are rapidly cleared upon ART initiation during acute HIV infection.

Authors:  Louise Leyre; Eugène Kroon; Claire Vandergeeten; Carlo Sacdalan; Donn J Colby; Supranee Buranapraditkun; Alexandra Schuetz; Nitiya Chomchey; Mark de Souza; Wendy Bakeman; Rémi Fromentin; Suteeraporn Pinyakorn; Siriwat Akapirat; Rapee Trichavaroj; Suthat Chottanapund; Sopark Manasnayakorn; Rungsun Rerknimitr; Phandee Wattanaboonyoungcharoen; Jerome H Kim; Sodsai Tovanabutra; Timothy W Schacker; Robert O'Connell; Victor G Valcour; Praphan Phanuphak; Merlin L Robb; Nelson Michael; Lydie Trautmann; Nittaya Phanuphak; Jintanat Ananworanich; Nicolas Chomont
Journal:  Sci Transl Med       Date:  2020-03-04       Impact factor: 17.956

8.  mTOR signaling mediates effects of common gamma-chain cytokines on T cell proliferation and exhaustion: implications for HIV-1 persistence and cure research.

Authors:  Harry E Taylor; Nina A Calantone; Richard T D'Aquila
Journal:  AIDS       Date:  2018-11-28       Impact factor: 4.177

9.  The gift of a lifetime: analysis of HIV at autopsy.

Authors:  Frank Maldarelli
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

10.  Dual TLR2 and TLR7 agonists as HIV latency-reversing agents.

Authors:  Amanda B Macedo; Camille L Novis; Caroline M De Assis; Eric S Sorensen; Paula Moszczynski; Szu-Han Huang; Yanqin Ren; Adam M Spivak; R Brad Jones; Vicente Planelles; Alberto Bosque
Journal:  JCI Insight       Date:  2018-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.